Harvest Volatility Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,336
Closed -$1.16M 115
2021
Q2
$1.16M Buy
6,336
+1,564
+33% +$268K 0.09% 82
2021
Q1
$730K Buy
4,772
+1,834
+62% +$284K 0.07% 94
2020
Q4
$459K Buy
+2,938
New +$378K 0.05% 93

Other funds holding ALXN

Harvest Volatility Management's ALXN Position: Q3 2021 in Review

Harvest Volatility Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 6,336 shares — an estimated $1.16M sold.

Harvest Volatility Management first reported a position in ALXN in Q4 2020 and held it in 3 quarters. The position peaked at $1.16M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Harvest Volatility Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Harvest Volatility Management sold 6,336 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.16M.
  • Harvest Volatility Management first reported a position in Alexion Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Harvest Volatility Management's Alexion Pharmaceuticals position peaked at $1.16M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Harvest Volatility Management's 13F filing for Q3 2021, filed 15 Nov 2021.